Compare AM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AM | ALKS |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.7B |
| IPO Year | 2017 | 2012 |
| Metric | AM | ALKS |
|---|---|---|
| Price | $22.59 | $48.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 14 |
| Target Price | $22.50 | ★ $43.43 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | ★ 3.61 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | $1,188,426,000.00 | ★ $1,475,899,000.00 |
| Revenue This Year | $4.84 | $24.26 |
| Revenue Next Year | $7.05 | $4.47 |
| P/E Ratio | $47.06 | ★ N/A |
| Revenue Growth | ★ 7.43 | N/A |
| 52 Week Low | $16.96 | $25.17 |
| 52 Week High | $23.84 | $55.67 |
| Indicator | AM | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 45.33 |
| Support Level | $22.23 | $47.66 |
| Resistance Level | $23.15 | $51.25 |
| Average True Range (ATR) | 0.55 | 1.40 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 78.39 | 30.25 |
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.